Chimeric antigen receptor (CAR) T-cell therapy has revolutionized the treatment of relapsed or refractory hematologic malignancies. While its clinical efficacy is well established, CAR T-cell therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback